|1.||Spontaneous Abortion (Miscarriage)
|5.||Congenital Abnormalities (Deformity)
|1.||Romero, Roberto: 14 articles (03/2016 - 01/2005)|
|2.||Chaiworapongsa, Tinnakorn: 14 articles (03/2016 - 01/2005)|
|3.||Hassan, Sonia S: 12 articles (03/2016 - 08/2009)|
|4.||Yeo, Lami: 11 articles (03/2016 - 08/2009)|
|5.||Dong, Zhong: 8 articles (01/2015 - 03/2010)|
|6.||Chen, Yuan-Hua: 8 articles (07/2012 - 12/2005)|
|7.||Wang, Hua: 8 articles (07/2012 - 12/2005)|
|8.||Xu, De-Xiang: 8 articles (07/2012 - 12/2005)|
|9.||Kim, Chong Jai: 6 articles (03/2016 - 10/2003)|
|10.||Mittal, Pooja: 6 articles (11/2011 - 08/2009)|
|1.||Dinoprostone (PGE2)FDA Link
01/01/1983 - "We conclude that intracervical instillation of 1.0 mg of PGE2 in viscous gel is a safe and effective method both for dilating the cervix before dilatation and evacuation and as a method of inducing labor in patients with intrauterine fetal death."
04/01/1997 - "The objective was to compare the effectiveness and efficacy of prostaglandin E2 (prepidil gel) plus oxitocin with that of intravenous oxitocin in the treatment of delivery induction in patients complicated with fetal death. "
02/01/1989 - " This study evaluated the results of PGE2 treatment in 85 patients seen at the center during an 18-month period, the majority (65%) of whom were delivered because of fetal death. "
08/01/1997 - " The median number of 20 mg PGE2 doses required was greater in the fetal malformation group (4, range 1-10) than the fetal death group (3, range 1-6). "
08/01/1997 - "Patients who undergo second-trimester induction of labor for major fetal malformations using intravaginal PGE2 should be counseled that the dosage of the drug is greater and that labor may last longer than in pregnancies complicated by a previous fetal death. "
|2.||Misoprostol (Cytotec)FDA LinkGeneric
03/01/2014 - "To assess whether buccal misoprostol is effective for the treatment of intrauterine fetal death. "
02/01/2014 - "Misoprostol is effective for induction of labor in case of second or third fetal death or termination of pregnancy. "
06/01/2004 - "400 micro g oral misoprostol every 4 h is effective for pregnancy termination in cases of intrauterine fetal death and may be an alternative regimen because of its ease and convenience."
02/01/2014 - "Misoprostol is effective and safe for induction of labor in case of second or third trimester fetal death or termination of pregnancy."
02/01/2014 - "Study, based on the literature, of the use of misoprostol for induction of labor in cases of second or third trimester fetal death or termination of pregnancy and define the different mode of administration. "
11/01/2008 - "To study the efficacy of intravenous sulprostone (Nalador) for the termination of pregnancy with fetal death in second and early third trimester of pregnancy. "
11/01/2008 - "We found sulprostone an efficient drug for termination of pregnancy with fetal death in second and early third trimester of pregnancy."
11/01/2008 - "Use of intravenous sulprostone for the termination of pregnancy with fetal death in second and early third trimester of pregnancy."
03/01/1990 - "[The use of sulprostone for voluntary interruption of gestation and in intrauterine fetal death]."
01/01/1990 - "Induction of labor in intrauterine fetal death with 16-phenoxy-prostaglandin-E2-methylsulfonylamide (sulprostone)--effects on uterine contractility, coagulation and kallikrein-kinin systems."
06/15/2004 - "To evaluate the efficacy of a uniform management protocol in antiphospholipid-antibody-positive obstetric patients with at least one second- or third-trimester intra-uterine fetal death. "
11/01/1991 - "Antiphospholipid antibody measurements obtained at 15 weeks' gestation or later in the general pregnancy population are not helpful in identifying pregnancies at risk for fetal death."
07/01/2012 - "To investigate the association of antiphospholipid antibodies and a history of intrauterine fetal death (IUFD) in a case-control design. "
07/01/2012 - "The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study."
06/15/2004 - "A prospective study of 33 successive pregnancies in antiphospholipid-antibody-positive patients, diagnosed after an intra-uterine fetal death. "
|5.||Ursodeoxycholic Acid (Urso)FDA LinkGeneric
06/01/2010 - "Ursodeoxycholic acid appears to be the most effective medication to improve maternal pruritus and liver-function tests; however, there is no medication to date that has been shown to reduce the risk for fetal death."
01/01/2014 - "Here, we report for the first time a 24-year Japanese case of severe ICP diagnosed by typical symptoms, serum biochemical analysis, and treated with the administration of ursodeoxycholic acid which improved cholestasis and liver injury and prevented fetal death. "
02/01/2006 - "We report a case of fetal death in a patient with intrahepatic cholestasis of pregnancy who had responded well to ursodeoxycholic acid, demonstrated by a low bile level. "
02/01/2006 - "Treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy reduces concentration of transaminases and bile acids in maternal serum, and is thought to reduce fetal death. "
|6.||Heparin (Liquaemin)FDA LinkGeneric
09/01/2003 - "Prevention for adverse outcomes with a low fixed dose of heparin may only be discussed in women with previous late fetal loss or intrauterine fetal death."
05/01/1995 - "[Uterine artery Doppler flow velocimetry in patients with recurrent intrauterine fetal death treated with anticoagulant heparin therapy]."
11/01/1983 - "[Prevention of repeated fetal death in utero with heparin therapy]."
02/01/1967 - "Heparin in the treatment of hypofibrinogenemia complicating fetal death in utero."
05/01/2012 - "Heparin seems to be effective in ameliorating pregnancy outcome in thrombophilic women with previous recurrent pregnancy loss, preeclampsia, intrauterine growth restriction and sudden fetal death. "
|7.||Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/01/2005 - "Low dose aspirin was empirically prescribed in one woman whose APS had been undiagnosed despite a history of two fetal deaths. "
05/01/1997 - "One woman in the aspirin group had a fetal death, and one in the usual care group had a low-birth-weight infant. "
11/01/1994 - "In B group, babies were obtained successfully in 8 cases by steroid-aspirin therapy, but intrauterine fetal death occurred in the second trimester in 2 cases, and in the other 2 cases early abortion occurred. "
01/01/2002 - "Considering the clear risk of complications during pregnancy -- especially the occurrence of spontaneous abortion in the first trimester -- and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication. "
08/01/1993 - "Aspirin ingestion in humans and animals has been reported to lead to a range of undesirable outcomes, including fetal death, growth retardation, and congenital abnormalities. "
|8.||Prednisone (Sone)FDA LinkGeneric
04/01/1990 - "Efficacy of prednisone treatment to prevent recurrent fetal death."
09/09/2003 - "The patient was treated with prednisone 20 mg per day but fetal death occurred at 29 weeks of gestation. "
07/01/1992 - "In live born infants, a low birth weight could be predicted by the presence of anticardiolipin antibodies (p = 0.034), prior intrauterine fetal death (p = 0.025), and treatment with high-dose prednisone (p = 0.002). "
01/01/1989 - "In women with a previous intrauterine fetal death related to lupus anticoagulant (LAC), we studied the effect of prednisone and calcieparine treatment to enable longer intrauterine life, increased fetal growth and increased survival rate. "
02/01/2005 - "One woman became pregnant after in vitro fertilisation and embryo transfer, but pregnancy ended in fetal death despite prednisone, hydroxychloroquine, and enoxaparin. "
01/01/2014 - "These results suggest ITE and TCDD differentially regulate the vascular remodeling of rat placentas, as well as the expression of angiogenic factors and their receptors, which in turn may alter the blood flow in the late gestation and partially resulted in intrauterine fetal death. "
11/01/2011 - "Pregnant rats exposed to TCDD showed a modest incidence of fetal death, fetal growth restriction and fetal malformation. "
02/15/2009 - "On the other hand, in utero exposure to TCDD markedly suppressed the development of sinusoids and trophoblast cells and the apoptosis of trophoblast cells with a concomitant increase in the incidence of fetal death under hypoxic condition. "
05/01/2006 - "Taken together, the above-described findings indicate that the higher susceptibility of HLZ rats to TCDD-induced placental dysfunction and fetal death may be modulated by other factor(s) in the genetic background of HLZ rats than the AhR."
05/01/2006 - "In order to investigate the mechanism underlying the TCDD-induced fetal death, we compared two outbred strains of rats, namely, the HLZ and the Sprague-Dawley International Genetic Standard rats (SD-IGS), a strain with characteristics resembling those of the HLZ rats. "
|10.||Cocaine (Cocaine HCl)IBA
02/01/1998 - "Compared with controls, the cocaine users had significantly higher Hobel Prenatal and Total Risk Scores and more preterm infants (28 vs 14), but not a significantly greater number of fetal deaths (3 vs 1). "
04/01/1996 - "There was a significantly higher intrauterine fetal death rate in the cocaine positive group (18.2% versus 0%, p = 0.02). "
12/01/1994 - "An unusual case of maternal-fetal death due to vaginal insufflation of cocaine."
09/01/1990 - "Toxicologic screening for cocaine and its metabolites was performed on 103 cases of fetal death autopsied in the Office of Chief Medical Examiner, City of New York. "
09/01/1990 - "Cocaine and fetal death."
|1.||Cesarean Section (Caesarean Section)
11/01/1976 - "The present study shows that significant improvement has been made in reducing cesarean section deaths, morbidity, and complications, as well as fetal deaths. "
04/01/2006 - "Fetal deaths from ruptured uterus represented 32.4% of all fetal loss following caesarean section during the study period. "
05/30/2002 - "After exclusion because of induction of labour, planned Caesarean section, breech delivery, twin delivery and intrauterine fetal death, 2,122 women were included in the study. "
09/01/1986 - "Caesarean section did not appear to be a risk factor in this population, but further studies covering more recent times and including fetal deaths are needed."
03/01/2014 - "Cesarean sections and fetal death rates."
11/01/2006 - "Of the risk factors associated with fetal death, the main one is a deficient prenatal care, that of being improved, might diminish the association of some other variables that were associated with fetal death."
03/01/2006 - "The study also found that less-educated women, mothers who did not attend for prenatal care and women with a history of abortions and fetal death were at an increased risk of fetal death. "
01/01/2006 - "Beginning in 1964 and every eight years thereafter through 1988, the National Center for Health Statistics (NCHS) conducted intensive national follow-back studies of live births and infant/fetal deaths, which has provided much of our more recent national epidemiologic information about pregnancy and births, especially concerning smoking, prenatal care usage, etc. A similar Department of Education/NCHS national follow-back and longitudinal follow-up study, the Early Childhood Longitudinal Study-Birth Cohort (ECLS-BC) was begun in 2001 and will survey 10,000 mothers and their infants through kindergarten age."
01/01/1992 - "This study identified a high-risk population of patients who did not qualify for medical assistance coverage and were de facto "uninsured." The results suggest that prenatal care for this high-risk population of uninsured patients can reduce the fetal death rate."
07/01/2015 - "After controlling for maternal age, race/ethnicity, level of prenatal care, and maternal comorbidities, the odds of fetal death remained 1.21 times higher (95% CI 1.05-1.41) and 1.28 times higher at ≤28 weeks' gestational age (95% CI 1.03-1.60). "
12/01/1984 - "[Medical clinical responsibility in control studies in pregnancy and curettage of the uterus long after fetal death]."
06/01/2007 - "In 7 of 14 (50%) cases with available medical history, the catastrophic APS appeared during pregnancy, in 6 (43%) during the puerperium and in 1 (7%) after curettage for a fetal death. "
01/01/1998 - "This led to intrauterine fetal death, which was terminated by curettage of the uterine cavity. "
03/01/1997 - "Also there has been presented detailed description of endocervix curettage after fetal death confirmed ultrasonographically. "
06/01/1986 - "Fetal death necessitated abortion by curettage."
|5.||Heart Valve Prosthesis
09/01/2005 - "Pregnancy in a woman with thrombosis of heart valve prosthesis at the 25th week of gestation and fetal death during reimplantation of prosthesis with the use of extracorporeal circulation. "
09/01/1984 - "It is concluded that (1) women with cardiac valve prostheses should be counseled against becoming pregnant, (2) antiplatelet agents do not provide protection against thromboembolism in these patients, (3) because of the high incidence of fetal death and birth defects use of coumarinics is contraindicated in the first trimester and the last weeks of pregnancy, (4) the substitution of heparin at these times may decrease the incidence of these complications, and (5) bioprostheses are indicated in women who wish to bear children."